Shandong Buchang Pharmaceuticals Co (SHSE:603858) Total Equity: ¥9,621 Mil (As of Mar. 2026)

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

Shandong Buchang Pharmaceuticals Co Ltd SHSE:603858

70 GF Score

Price ¥15.66

GF Value ¥15.94

Valuation Fairly Valued

6 Warning Signs

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

What is Shandong Buchang Pharmaceuticals Co Total Equity?

Shandong Buchang Pharmaceuticals Co SHSE:603858 -0.89% 70 Total Equity is ¥9,621 Mil as of Mar. 2026. GuruFocus rates SHSE:603858 with a GF Score™ of 70/100 and a GF Value™ of ¥15.94 (Fairly Valued). The stock has 6 warning signs investors should review.

Shandong Buchang Pharmaceuticals Co's total equity for the quarter that ended in Mar. 2026 was ¥9,621 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Try GuruFocus Premium free for 7 days

Unlock GF Score, GF Value, 30-Y financials, and pro screeners.

Get Started →

Shandong Buchang Pharmaceuticals Co Total Equity Related Terms

Shandong Buchang Pharmaceuticals Co Total Equity Historical Data

* Premium members only.

The historical data trend for Shandong Buchang Pharmaceuticals Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Buchang Pharmaceuticals Co Total Equity Chart

Shandong Buchang Pharmaceuticals Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Total Equity

Get a 7-Day Free Trial

14,322.88

12,275.05

11,376.01

9,808.08

9,436.43

Shandong Buchang Pharmaceuticals Co Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Total Equity	Get a 7-Day Free Trial															10,050.94	10,282.38	10,072.08	9,436.43	9,620.77

70GF Score

Shandong Buchang Pharmaceuticals Co Ltd SHSE:603858

Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

Shandong Buchang Pharmaceuticals Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Shandong Buchang Pharmaceuticals Co's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2025 )	-	Total Liabilities(Q: Dec. 2025 )
	=	19244.71	-	9808.276
	=	9,436

Shandong Buchang Pharmaceuticals Co's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity	=	Total Assets(Q: Mar. 2026 )	-	Total Liabilities(Q: Mar. 2026 )
	=	19640.475	-	10019.71
	=	9,621

Frequently Asked Questions Learn more about Total Equity →

What does a Total Equity of ¥9,621 Mil mean?

Shandong Buchang Pharmaceuticals Co (SHSE:603858) has a Total Equity of ¥9,621 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Shandong Buchang Pharmaceuticals Co and its competitors.

Is Shandong Buchang Pharmaceuticals Co's Total Equity too high?

Shandong Buchang Pharmaceuticals Co's current Total Equity is ¥9,621 Mil. Overall, Shandong Buchang Pharmaceuticals Co has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Shandong Buchang Pharmaceuticals Co's Total Equity compare to ZTS?

Shandong Buchang Pharmaceuticals Co's Total Equity of ¥9,621 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Equity for a Drug Manufacturers company?

A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Equity mean?

A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Shandong Buchang Pharmaceuticals Co and its competitors. Shandong Buchang Pharmaceuticals Co's current Total Equity is ¥9,621 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Shandong Buchang Pharmaceuticals Co stock overvalued right now?

Based on GuruFocus' analysis, Shandong Buchang Pharmaceuticals Co (SHSE:603858) is currently considered Fairly Valued. The stock's GF Value™ is ¥15.94, compared to a current price of ¥15.66 — trading 1.8% below its estimated fair value. The current Total Equity is ¥9,621 Mil. Shandong Buchang Pharmaceuticals Co's overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Equity calculated?

Total Equity is calculated from a company's financial statements. For Shandong Buchang Pharmaceuticals Co (SHSE:603858), the current Total Equity is ¥9,621 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shandong Buchang Pharmaceuticals Co (SHSE:603858) Overvalued in 2026?

Based on GuruFocus' analysis, Shandong Buchang Pharmaceuticals Co stock appears to be undervalued. The current stock price of ¥15.66 is trading 1.8% below its estimated GF Value™ of ¥15.94. GuruFocus considers Shandong Buchang Pharmaceuticals Co to be Fairly Valued.

Key valuation signals for SHSE:603858:

Total Equity: ¥9,621 Mil
GF Value™: ¥15.94 vs. price of ¥15.66 (1.8% below fair value)
GF Score™: 70/100 with 6 warning signs

No single metric tells the full story. See the SHSE:603858 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →